Senior Medical Evidence & Implementation Strategist

Boehringer Ingelheim Pharmaceuticals, Inc.; Ridgefield (CT); Presencial; USD 191 000 - 294 000; Tempo integral

Resumo da oferta

Boehringer Ingelheim Pharmaceuticals, Inc. is seeking an Associate Director / Sr. Associate Director, CEIL, to lead medical-scientific engagement across Respiratory / Emerging Areas for priority accounts.

You will diagnose care-delivery gaps, implement evidence-based interventions, and partner with account teams to drive guideline-directed treatment adoption. The role emphasizes independent judgment in portfolio management, collaboration with Medicine, and advancing account-based scientific

Qualificações

• Master's degree in a scientific discipline required (e.g. MSc) with minimum 5 years in pharma/healthcare, 2 years in customer-facing or management/market access.
• Bachelor's degree with Healthcare Professional License (e.g. RPh) with minimum 7 years in pharma/healthcare, including 3 years in customer-facing role or management/market access.

Responsabilidades

• Provide account insights to support TA account objectives and coordinate with CEIL leadership and account teams.
• Engage clinicians, quality leaders, pharmacy, IT/informatics, care coordination, and executives to gather scientific insights across accounts.
• Assess barriers across the patient journey and identify opportunities to improve diagnosis, referral, initiation of treatment and follow-up.

Conhecimentos

Scientific expertise

Account management

Stakeholder engagement

Implementation Science

Formação académica

MSc/PhD or equivalent in scientific discipline

Bachelor’s degree with Healthcare Professional License (e.g., RPh)

Descrição da oferta de emprego

Boehringer Ingelheim Pharmaceuticals, Inc. is seeking an Associate Director / Sr. Associate Director, CEIL, to lead medical-scientific engagement across Respiratory / Emerging Areas for priority accounts.

You will diagnose care-delivery gaps, implement evidence-based interventions, and partner with account teams to drive guideline-directed treatment adoption. The role emphasizes independent judgment in portfolio management, collaboration with Medicine, and advancing account-based scientific